{"DataElement":{"publicId":"3813824","version":"1","preferredName":"Malignant Neoplasm Diagnosis Anatomic Site","preferredDefinition":"A respsonse related to the site(s) of cancer diagnosis.","longName":"3813790v1.0:3813817v1.0","context":"ECOG-ACRIN","contextVersion":"1","DataElementConcept":{"publicId":"3813790","version":"1","preferredName":"Malignant Neoplasm Diagnosis","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004_The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","longName":"2186369v1.0:2239981v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2186369","version":"1","preferredName":"Malignant Neoplasm","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E0647F5B-A888-4B87-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-08-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-08-03","modifiedBy":"DATA_LOADER","dateModified":"2005-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2239981","version":"1","preferredName":"Diagnosis","preferredDefinition":"The process of identifying a disease by the signs and symptoms.","longName":"C15220","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FD4EEB-1C71-0B27-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-26","modifiedBy":"ONEDATA","dateModified":"2005-06-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"E2339A47-2758-248E-E040-BB89AD4301B6","latestVersionIndicator":"Yes","beginDate":"2013-07-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-07-23","modifiedBy":"HARTLEYG","dateModified":"2018-06-06","changeDescription":"8/22/17 tt transferred context, added registration status and CSI per Round 5 finalization task. 7/14/15 released/t_7/23/13 curated for 6685. tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3813817","version":"1","preferredName":"Malignant Neoplasm Anatomic Site","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004._Named locations of or within the body.","longName":"3813817v1.0","context":"ECOG-ACRIN","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Larynx cancer","valueDescription":"Laryngeal Carcinoma","ValueMeaning":{"publicId":"3813819","version":"1","preferredName":"Laryngeal Carcinoma","longName":"3813819","preferredDefinition":"Carcinoma that arises from the laryngeal epithelium. More than 90% of laryngeal carcinomas are squamous cell carcinomas. The remainder are adenoid cystic carcinomas, mucoepidermoid carcinomas and carcinomas with neuroendocrine differentiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laryngeal Carcinoma","conceptCode":"C4855","definition":"Carcinoma that arises from the laryngeal epithelium. More than 90% of laryngeal carcinomas are squamous cell carcinomas. The remainder are adenoid cystic carcinomas, mucoepidermoid carcinomas and carcinomas with neuroendocrine differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2346CC1-C1AB-646B-E040-BB89AD434597","latestVersionIndicator":"Yes","beginDate":"2013-07-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-07-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EFF036CC-B900-C8DE-E040-BB89AD432361","beginDate":"2013-07-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-01-14","modifiedBy":"ONEDATA","dateModified":"2014-01-14","deletedIndicator":"No"},{"value":"Supraglottic cancer","valueDescription":"Supraglottic Carcinoma","ValueMeaning":{"publicId":"3813821","version":"1","preferredName":"Supraglottic Carcinoma","longName":"3813821v1.00","preferredDefinition":"A carcinoma of the larynx that arises from the supraglottic area.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Supraglottic Carcinoma","conceptCode":"C5973","definition":"A carcinoma of the larynx that arises from the supraglottic area.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2346CC1-C1D3-646B-E040-BB89AD434597","latestVersionIndicator":"Yes","beginDate":"2013-07-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-07-23","modifiedBy":"KUMMEROA","dateModified":"2023-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"EFF036CC-B916-C8DE-E040-BB89AD432361","beginDate":"2013-07-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-01-14","modifiedBy":"ONEDATA","dateModified":"2014-01-14","deletedIndicator":"No"},{"value":"Oropharynx cancer, including base of tongue and tonsil","valueDescription":"Oropharyngeal Carcinoma Base of the Tongue and Tonsil","ValueMeaning":{"publicId":"4155494","version":"1","preferredName":"Oropharyngeal Carcinoma Base of the Tongue and Tonsil","longName":"4155494","preferredDefinition":"Carcinoma, predominantly squamous cell, arising from the epithelial cells of the oropharynx.: The posterior one third of the tongue behind the terminal sulcus that forms the anterior aspect of the oro-pharynx responsible for swallowing and modification of the voice in speech.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: One of two small masses of lymphoid tissue on either side of the throat.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oropharyngeal Carcinoma","conceptCode":"C9105","definition":"Carcinoma, predominantly squamous cell, arising from the epithelial cells of the oropharynx.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Base of Tongue","conceptCode":"C12228","definition":"The posterior one third of the tongue behind the terminal sulcus that forms the anterior aspect of the oro-pharynx responsible for swallowing and modification of the voice in speech.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Tonsil","conceptCode":"C12802","definition":"The two organs situated in the throat on either side of the narrow passage from the mouth to the pharynx. They are composed of lymphoid tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F24CC9B7-21F6-EA83-E040-BB89AD436160","latestVersionIndicator":"Yes","beginDate":"2014-02-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-02-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F24CC9B7-220F-EA83-E040-BB89AD436160","beginDate":"2014-02-13","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-02-13","modifiedBy":"ONEDATA","dateModified":"2014-02-13","deletedIndicator":"No"},{"value":"Oral cavity cancer","valueDescription":"Oral Cavity Carcinoma","ValueMeaning":{"publicId":"3813823","version":"1","preferredName":"Oral Cavity Carcinoma","longName":"3813823","preferredDefinition":"Cancer that forms in tissues of the oral cavity (the mouth). The tissues of the oral cavity include the lips, the lining inside the cheeks and lips, the front two thirds of the tongue, the upper and lower gums, the floor of the mouth under the tongue, the bony roof of the mouth, and the small area behind the wisdom teeth.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oral Cavity Carcinoma","conceptCode":"C8990","definition":"A carcinoma arising in the oral cavity.  Most oral cavity carcinomas are squamous cell carcinomas of the tongue, buccal mucosa, or gums.  Less frequent morphologic variants include mucoepidermoid carcinoma and adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2346CC1-C211-646B-E040-BB89AD434597","latestVersionIndicator":"Yes","beginDate":"2013-07-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-07-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F24CC9B7-2223-EA83-E040-BB89AD436160","beginDate":"2013-07-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-02-13","modifiedBy":"ONEDATA","dateModified":"2014-02-13","deletedIndicator":"No"},{"value":"None of the above","valueDescription":"None","ValueMeaning":{"publicId":"2577064","version":"1","preferredName":"None","longName":"2577064","preferredDefinition":"No person or thing, nobody, not any.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None","conceptCode":"C41132","definition":"No person or thing, nobody, not any.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA15-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-22","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-22","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F35289DF-4F4A-7CBA-E040-BB89AD433897","beginDate":"2014-02-26","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-02-26","modifiedBy":"ONEDATA","dateModified":"2014-02-26","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008526","version":"1","preferredName":"Anatomic Sites","preferredDefinition":"locations or structures in the human body.","longName":"ANAT_SITES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1ED0F8B-4D91-332D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4092991","version":"1","preferredName":"Malignant Neoplasm Anatomic Site","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.:Named locations of or within the body.","longName":"C9305:C13717","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Anatomic Site","conceptCode":"C13717","definition":"Named locations of or within the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EFF036CC-B8B1-C8DE-E040-BB89AD432361","latestVersionIndicator":"Yes","beginDate":"2014-01-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2014-01-14","modifiedBy":"ONEDATA","dateModified":"2014-01-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2346CC1-C192-646B-E040-BB89AD434597","latestVersionIndicator":"Yes","beginDate":"2013-07-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-07-23","modifiedBy":"KUMMEROA","dateModified":"2023-09-24","changeDescription":"7/14/15 released/tt_2/26/14 edit to PV. tt 7/23/13 curated for 6685.","administrativeNotes":"2023.9.24 Updated def for 'No Value Exists'. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3314482","version":"1","longName":"Type of Category","context":"ECOG-ACRIN","ClassificationSchemeItems":[{"publicId":"10000277","version":"1","longName":"Eligibility","context":"ECOG-ACRIN"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Does the participant have one","type":"Preferred Question Text","description":"Does the participant have one of the following?","url":null,"context":"ECOG-ACRIN"}],"origin":"ACRIN:American College of Radiology Imaging Network","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E234DFE3-4DCA-EF02-E040-BB89AD435584","latestVersionIndicator":"Yes","beginDate":"2013-07-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2013-07-23","modifiedBy":"TAYLORT","dateModified":"2015-07-14","changeDescription":"7/14/15 released/tt_1/14/14 change to VD and def. tt 7/23/13 curated for 6685.tt","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}